Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biodetection & Biosensors 2017


Microfluidics & Hypermobility for Health 4.0

Ali Tinazli, Chief Business Officer, FLUXERGY

New imperatives of healthcare are focusing on prevention, personalization of diagnostics and treatment, and democratization, including access to everyone, anywhere, anytime at a low cost. This imperative is based on two pillars: ubiquitously distributed (decentralized) diagnostics tools for capturing the health status and processing of the data into personalized, readily accessible and actionable health information. The decentralized diagnostics tools will require low power, connected, commercial mobility devices driving affordable high-tech, low cost microfluidics cartridges—technically similar to the microfluidics cartridges for inkjet printers—to interrogate by biochemical means the health status. The clinically relevant data obtained will be processed with machine learning and AI tools on-site to provide immediate insight into the patient’s health condition. The technology convergence in medicine is enabled by the powerful combination of microelectronics, microfluidics, distributed network and data analytics.

Add to Calendar ▼2017-10-10 00:00:002017-10-11 00:00:00Europe/LondonBiodetection and Biosensors 2017Biodetection and Biosensors 2017 in Murray Edwards College, Cambridge, UKMurray Edwards College, Cambridge,